Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children

NCT04484935 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

RSV Infection

Interventions

DRUG: Nirsevimab

Sponsor

AstraZeneca

Collaborators

[object Object]